cyber security
Securing Computation with Yael Kalai
Yael Kalai
Adjunct Associate Professor, MIT EECS
Professor Yael Kalai of MIT CSAIL and Senior Principal Researcher at Microsoft Research New England is a cryptographer and theoretical computer scientist working on state-of-the-art ways of securing computation.
D. Fox Harrell virtuality
Designing and Using Virtuality to Better Serve Us
D. Fox Harrell
Professor, MIT CSAIL
Our new reality is increasingly one of virtuality. D. Fox Harrell, P.h.D., studies the relationship between computing and imagination for emerging forms of digital media, as well as their social and ethical impact.
robot dexterity
Enabling Robots to Complete Tasks on a Human Level
Edward (Ted) Adelson
Professor, MIT Brain and Cognitive Sciences

If we want robots to assist us with everyday tasks, they’ll need to be able to manipulate objects on a human level. To do that, they need good fingers. Professor Ted Adelson of MIT CSAIL is developing robotic fingers that are sensitive and soft like human fingers, enabling robots to use their hands intelligently to accomplish chosen tasks.

Moore's Law podcast
Moore's Law Momentum with CSAIL's Saman Amarasinghe
Saman Amarasinghe
Professor, MIT EECS

“If we want to keep the Moore’s Law momentum going in computing, we have to do something different,” says CSAIL Professor Saman Amarasinghe, whose work with compilers is making them faster, more reliable, and more efficient. He discusses using new technologies like machine learning and modern algorithms and solvers to optimize code and get the performance needed to keep up with the rapid changes happening in industry.

human genome
Understanding the Science of Disease Through Human Genome Research with Manolis Kellis
Manolis Kellis
Professor, MIT CSAIL

MIT CSAIL Professor Manolis Kellis discusses how the symbiotic relationship between computer science and biology helps us to better understand the complex programming language that is our DNA. Through DNA, we can find the molecular basis of the pathophysiology of a disease and take a more holistic approach to disease treatment, and one day may even predict disease. He explains the impact of human genome and epigenome research on the pharmaceutical industry in developing medicine that is both precise and personalized, dramatically transforming the therapeutic landscape.